Another vaccine?
Hello my friends,
It's been a while since I last posted. I have been monitoring the markets and making sure I can find a good deal before I share it with you all.
So I have been following
JNJ for some time now. JNJ is currently in their trail 3 of their vaccine efforts and should be concluding sometime this month. You probably think the hype for vaccine is over due to 
PFE and 
MRNA already taking the spotlight, but I don't believe that is so. JNJ will be the first vaccine that only requires 1 shot and no follow up. This is a huge difference in many aspects, logistically and personally. Logistically, you ship 50% less product to the same consumer base as the previously mentioned companies. Also consider the vas number of people seeking the vaccine every year. JNJ has a yearly goal of distributing 1 billion vaccines worldwide, every year. Personally, people are already hesitant when it comes to the vaccine. Those who are hesitant are put off by a 2 shot system, it's just not a viable long-term solution. A 1 shot system is what will stick around for years to come. Also, JNJ is a trusted name worldwide so I believe it will be the primary choice for yearly vaccinations. On December 1st we had a random spike in price, I believe their is talk about the vaccine and it must be good news, of course this is just speculation.
TA:
All red lines are points of resistance. When/if the price closes above it, it should leap in price.
First Resistance at 148.72; we are currently struggling with this price for the past few days, if we can close above this, price is free to run up to around 150.00
Other red resistance lines are created from previous highs in price range, with 156.94 being the previous ATH
Orange tread lines: This is the channel we have been bouncing around in for the past few months. I believe vaccine news will allow us to break through this range
Fibonacci retracement is in gray/white. This was built off the dip created in March after COVID. It seems to hold true
TL;DR:
BULLISH FOR 3-6 MONTHS. If vaccine news is positive, JNJ will run up dramatically in price. JNJ is known known for gapping up on good news.
Positions:
Safe bet: Shares, hold until next EPS
Moderate risk bet: Outdated calls for next year around March
High risk bet: End of the month calls, banking on vaccine reveal
It's been a while since I last posted. I have been monitoring the markets and making sure I can find a good deal before I share it with you all.
So I have been following
JNJ for some time now. JNJ is currently in their trail 3 of their vaccine efforts and should be concluding sometime this month. You probably think the hype for vaccine is over due to PFE and MRNA already taking the spotlight, but I don't believe that is so. JNJ will be the first vaccine that only requires 1 shot and no follow up. This is a huge difference in many aspects, logistically and personally. Logistically, you ship 50% less product to the same consumer base as the previously mentioned companies. Also consider the vas number of people seeking the vaccine every year. JNJ has a yearly goal of distributing 1 billion vaccines worldwide, every year. Personally, people are already hesitant when it comes to the vaccine. Those who are hesitant are put off by a 2 shot system, it's just not a viable long-term solution. A 1 shot system is what will stick around for years to come. Also, JNJ is a trusted name worldwide so I believe it will be the primary choice for yearly vaccinations. On December 1st we had a random spike in price, I believe their is talk about the vaccine and it must be good news, of course this is just speculation. TA:
All red lines are points of resistance. When/if the price closes above it, it should leap in price.
First Resistance at 148.72; we are currently struggling with this price for the past few days, if we can close above this, price is free to run up to around 150.00
Other red resistance lines are created from previous highs in price range, with 156.94 being the previous ATH
Orange tread lines: This is the channel we have been bouncing around in for the past few months. I believe vaccine news will allow us to break through this range
Fibonacci retracement is in gray/white. This was built off the dip created in March after COVID. It seems to hold true
TL;DR:
BULLISH FOR 3-6 MONTHS. If vaccine news is positive, JNJ will run up dramatically in price. JNJ is known known for gapping up on good news.
Positions:
Safe bet: Shares, hold until next EPS
Moderate risk bet: Outdated calls for next year around March
High risk bet: End of the month calls, banking on vaccine reveal
免責聲明
這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。